Skip to main content
. 2023 Feb 2;4(1):e238. doi: 10.1097/AS9.0000000000000238

TABLE 1.

Demographic and Health Characteristics of Individuals Undergoing Cholecystectomy, 2003–2020*

Overall Bile Duct Injury No Bile Duct Injury
(N = 769,782) (N = 894) (N = 768,888)
Sex
 Female 241,370 (31.4) 465 (52.0) 527,518 (68.6)
 Male 527,983 (68.6) 429 (48.0) 241,370 (31.4)
Age, y
 18–34 145,075 (18.8) 87 (9.7) 144,988 (18.9)
 35–44 138,540 (18.0) 105 (11.7) 138,435 (18.0)
 45–54 149,866 (19.5) 140 (15.7) 149,726 (19.5)
 55–64 128,805 (16.7) 175 (19.6) 128,630 (16.7)
 65+ 207,496 (27.0) 387 (43.3) 207,109 (26.9)
Race/ethnicity
 Asian 15,482 (2.0) 29 (3.2) 15,453 (2.0)
 Black 64,708 (8.4) 85 (9.5) 64,623 (8.4)
 Hispanic 94,577 (12.3) 111 (12.4) 94,466 (12.3)
 White 507,103 (65.9) 565 (63.2) 506,538 (65.9)
Region
 Midwest 198,759 (25.8) 183 (20.5) 198,576 (25.8)
 Northeast 19,423 (2.5) 23 (2.6) 19,400 (2.5)
 South 410,746 (53.4) 460 (51.5) 410,286 (53.4)
 West 139,970 (18.2) 226 (25.3) 139,744 (18.2)
Type
 Open 36,667 (4.5) 488 (54.6) 36,179 (4.7)
 Laparoscopic 733,115 (95.2) 406 (45.4) 732,709 (95.3)
Indications for surgery§
 Biliary colic 550,159 (71.5) 553 (61.9) 549,606 (71.4)
 Cholecystitis 698,948 (90.8) 826 (92.4) 698,122 (90.8)
 Other gallbladder disease 304,582 (39.6) 500 (55.9) 304,082 (39.5)
 Diseases of the pancreas 51,816 (6.7) 182 (20.4) 51,634 (6.7)
Comorbidities§
 Obesity 173,797 (22.6) 159 (17.8) 173,638 (22.6)
 Coronary artery disease 103,940 (13.5) 191 (21.4) 103,749 (13.5)
 Atrial fibrillation 39,610 (5.1) 106 (11.8) 39,504 (5.1)
 Chronic kidney disease 48,446 (6.3) 99 (11.1) 48,347 (6.3)
 Chronic liver disease 116,367 (15.1) 170 (19.0) 116,367 (15.1)

*Cholecystectomies were identified using CPT codes 47562, 47563, 47564, 47600, 47605, 47610, and 47620. Bile duct injuries were identified using CPT codes 47760, 47765, 47780, 47785, 47790, and 47800.

†Race/ethnicity was missing for 87,912 subjects (11.4%).

‡We defined US Census Regions as the Northeast (Connecticut, Massachusetts, Maine, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, Vermont,); the South (Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia); the Midwest (Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin); and the West (Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Washington, and Wyoming).

§Common indications were identified in the six weeks prior and three weeks after the date of cholecystectomy. Comorbidities identified within the 365 days that preceded the date of cholecystectomy.